This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_UTERUS_NAS_EXALLC for full statistics.
Malignant neoplasm of uterus, part unspecified
C3_UTERUS_NAS
uterine neoplasm: ['Tumors of the UTERUS.']
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule
Sex
only females
219462
Check conditions None
219462
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C55
Cause of death: ICD-8
182
Cause of death: excluded ICD-8
1820
Cancer registry: Topography ICD-O-3
C55
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
21
Check minimum number of events None
21
Include endpoints None
21
Remove individuals based on genotype QC
21
C3_UTERUS_NAS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of uterus, part unspecified
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of uterus, part unspecified (controls excluding all cancers)
- malignant neoplasm of female genital organs (controls excluding all cancers)
- malignant neoplasm of female genital organs
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21 | 21 | - |
| Unadjusted prevalence (%) | 0.01 | 0.01 | - |
| Mean age at first event (years) | 60.84 | 60.84 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_UTERUS_NAS – Malignant neoplasm of uterus, part unspecified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of uterus, part unspecified
↥Endpoint not on priority list, no data to show.